Return to Article Details
IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION
Download
Download PDF